Milestones

Major corporate accomplishments and touchpoints that have driven our hi-tech innovative start-up.

09.2021

Inflammation-Focused Device Maker Tivic Health Systems Sets Terms for $15 Million IPO

09.2021

Tivic Health CEO Jennifer Ernst Wins Inc. Magazine’s Female Founder 100 Award

08.2021

Tivic Health Receives Award for The Top 100 Healthcare Technology Companies of 2021

06.2021

Jennifer Ernst, CEO and Co-Founder of Tivic Health Receives Award for Top 25 Women Leaders in Consumer HealthTech of 2021

03.2021

FDA Expands Indication for Use of Tivic Health’s ClearUP Sinus Pain Relief to Include Congestion for Common Cold, Flu and Allergies

09.2020

USPTO Grants Tivic’s First Four Patents

04.2020

Fast Company 2020 World Changing Ideas Award Finalist in Health & Fitness; Honorable Mention in Consumer Products

03.2020

ClearUP Receives CE Mark Approval

02.2020

ClearUP named Editors’ Pick: CES 2020 Top Tech Digital Trends

11.2019

Tivic Health named CES 2020 Innovation Awards Honoree

11.2019

ClearUP Receives ISO 13485:2016 Certification

11.2019

ClearUP named to TIME’s list of 100 Best Inventions of 2019

09.2019

September product shipment

08.2019

Finalist in MedTech Insight Awards: Most Innovative Team or Innovator of the Year

07.2019

$8 million seed funding closed

01.2019

FDA 510K Clearance

01.2019

Top Pick at CES award from Techlicious

01.2019

Best of CES award from Gear Diary

10.2018

Runner-up for Best Clinical Manuscript at the ARS Annual Meeting for Stanford/Tivic paper


10.2018

Received Best Gold Electrode Award for Most Promising Start-up from the Neurotech Leaders Forum

07.2018

510(k) submission accepted by FDA, K-number issued

05.2018

71 patient double-blind RCT completed at Stanford Sinus Center

05.2018

Pivotal study completed for FDA submission, met agreed endpoint

04.2018

Tivic Health files international patent applications

01.2018

Double-blind, randomized, placebo-controlled study initiated at Stanford Sinus Center

09.2016

Company Incorporated

blank